Literature DB >> 9152675

Management of atrial fibrillation in the setting of heart failure.

H J Crijns1, M P Van den Berg, I C Van Gelder, D J Van Veldhuisen.   

Abstract

Heart failure is often complicated by atrial fibrillation. Once atrial fibrillation has started it further enhances heart failure due to uncontrolled rate with shortened filling time and provocation of tachycardiomyopathy. Absent atrial kick and irregularity of the ventricular rhythm also contribute. Considering these mechanisms, restoration of sinus rhythm is most beneficial but is associated with frequent recurrences. Before cardioversion heart failure must be treated. ACE inhibition, initiated before cardioversion, may enhance maintenance of sinus rhythm by reducing neurohumoral activation. As a consequence, arrhythmogenic factors diminish and ventricular function may improve. beta-blockade and amiodarone may have similar effects. If cardioversion fails, adequate rate control is mandatory to prevent progressive ventricular dysfunction. Digitalis is the treatment of first choice, but when the heart rate remains uncontrolled low-dose beta-blockade should be given. If the ventricular rate remains uncontrolled despite drugs, atrioventricular node ablation with implantation of a pacemaker may be considered. Not only patients with idiopathic heart failure and atrial fibrillation, but also those with significant underlying heart disease may benefit from this intervention. In atrial fibrillation patients undergoing cardiac surgery for heart failure due to valvular disease, additional arrhythmia surgery may be contemplated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152675     DOI: 10.1093/eurheartj/18.suppl_c.45

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

Review 1.  Regenerative therapies in electrophysiology and pacing.

Authors:  Michael R Rosen; Peter R Brink; Ira S Cohen; Peter Danilo; Richard B Robinson; Amy B Rosen; Matthias J Szabolcs
Journal:  J Interv Card Electrophysiol       Date:  2008-03-25       Impact factor: 1.900

Review 2.  Assessing patients for catheter ablation during hospitalization for acute heart failure.

Authors:  Bradley P Knight; Jason T Jacobson
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

Review 3.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 4.  Prevention of and medical therapy for atrial arrhythmias in heart failure.

Authors:  A U Khand; J G F Cleland; P C Deedwania
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

5.  Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation.

Authors:  Trudeke Van Noord; Harry J G M Crijns; Maarten P van den Berg; Dirk J Van Veldhuisen; Isabelle C Van Gelder
Journal:  BMC Cardiovasc Disord       Date:  2005-01-24       Impact factor: 2.298

6.  Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.

Authors:  Nemin Chen; Aniqa B Alam; Pamela L Lutsey; Richard F MacLehose; J'Neka S Claxton; Lin Y Chen; Alanna M Chamberlain; Alvaro Alonso
Journal:  J Am Heart Assoc       Date:  2020-05-23       Impact factor: 5.501

7.  Heart failure patients with atrial fibrillation benefit from remote patient management: insights from the TIM-HF2 trial.

Authors:  Tina Stegmann; Kerstin Koehler; Rolf Wachter; Volker Moeller; Samira Zeynalova; Friedrich Koehler; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2020-06-17

Review 8.  Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes.

Authors:  Giuseppe Boriani; Marco Vitolo; Igor Diemberger; Marco Proietti; Anna Chiara Valenti; Vincenzo Livio Malavasi; Gregory Y H Lip
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 13.081

Review 9.  Arrhythmogenic Remodeling in the Failing Heart.

Authors:  Zoltán Husti; András Varró; István Baczkó
Journal:  Cells       Date:  2021-11-17       Impact factor: 6.600

10.  Outcomes following heart failure hospitalization in a regional Australian setting between 2005 and 2014.

Authors:  Mohammed S Al-Omary; Arshad A Khan; Allan J Davies; Peter J Fletcher; Dawn Mcivor; Bruce Bastian; Christopher Oldmeadow; Aaron L Sverdlov; John R Attia; Andrew J Boyle
Journal:  ESC Heart Fail       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.